摘要
目的探讨复方丹参滴丸对急性心肌梗死临床疗效的影响。方法将75例急性心肌梗死患者随机分为治疗组(A组)45例,对照组(B组)30例。两组病人均给予尿激酶溶栓,A组口服复方丹参滴丸,B组口服阿司匹林,疗程均为2周,观察两组患者血液流变学、QRS记分、梗死面积变化及临床疗效等情况。结果A组总有效率(97.78%)、血液流变学、QRS记分(4.45±0.82)、以及梗死面积(25.20±3.40)的改善均明显优于B组(P〈0.05或P〈0.01)。结论复方丹参滴丸对于急性心肌梗死具有较好的治疗作用。
Objective To observe the clinical curative effect of the FUFANGDANSHENDIWAN on the acute myocardial infarction patients. Methods 75 acute myocardial infarction patients were randomly divided into two groups ,the curative group( A group)45patients, and the control group (B group )30 patients, patients inTwo groups were treated wigh thrombolytie intravenous drip urokinas, A groupe patients oral admnistered the FUFANGDANSH- ENDIWAN, B group patients oral administered aspirin, the course of treatment is two weeks. The change of the level of blood rheology,the record points of QRS wave of the electrocardiogram, and the square of myocardial infarction were observed. Results The change of the level of blood rheology, the record points of QRS wave of the electrocardiogram (4. 45± 0. 82 ) , and the square of myocardial infarction ( 25.20 ± 3.40 ), of A group compared with B group, the difference is significant. ( P 〈 0. 05 orP 〈 0. 01 ). Conclusion The FUFANGDANSHENDIWAN had effect on the acute myocardial infarction.
出处
《中国基层医药》
CAS
2008年第10期1653-1654,共2页
Chinese Journal of Primary Medicine and Pharmacy